2-chloroadenosine has been researched along with bryostatin 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Katib, AM; Beck, FW; Mohammad, RM; Wall, NR | 1 |
| Al-Katib, AM; Beck, FW; Dandashi, MH; Eilender, DS; Godmere, MA; Mohammad, RM; Siddiq, F; Snell, DC | 1 |
2 other study(ies) available for 2-chloroadenosine and bryostatin 1
| Article | Year |
|---|---|
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line.
Topics: 2-Chloroadenosine; Aged; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Bryostatins; Deoxyadenosines; Enzyme Activators; Humans; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Macrolides; Male; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2001 |
Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Topics: 2-Chloroadenosine; 5'-Nucleotidase; Antimetabolites, Antineoplastic; Bryostatins; Cell Death; Deoxyadenosines; Deoxycytidine Kinase; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Macrolides; Nuclear Proteins; Protein Serine-Threonine Kinases; ras Proteins; Tumor Cells, Cultured | 2004 |